Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.

Abstract:

:SMARCB1 (Snf5/Ini1/Baf47) is a potent tumor suppressor, the loss of which serves as the diagnostic feature in malignant rhabdoid tumors (MRT) and atypical teratoid/rhabdoid tumors (AT/RT), two highly aggressive forms of pediatric neoplasms. SMARCB1 is a core subunit of Swi/Snf chromatin remodeling complexes, and loss of SMARCB1 or other subunits of these complexes has been observed in a variety of tumor types. Here, we restore Smarcb1 expression in cells derived from Smarcb1-deficient tumors, which developed in Smarcb1 heterozygous p53(-/-) mice. We find that while re-introduction of Smarcb1 does not induce growth arrest, it restores sensitivity to programmed cell death and completely abolishes the ability of the tumor cells to grow as xenografts. We describe persistent activation of AKT signaling in Smarcb1-deficient cells, which stems from PI3K (phosphatidylinositol 3'-kinase)-mediated signaling and which contributes to the survival and proliferation of the tumor cells. We further demonstrate that inhibition of AKT is effective in preventing proliferation of Smarcb1-deficient cells in vitro and inhibits the development of xenografted tumors in vivo. Profiling Smarcb1-dependent gene expression, we find genes that require Smarcb1 and Swi/Snf for their expression to be enriched for extracellular matrix and cell adhesion functions. We find that Smarcb1 is required for transcriptional activation of Igfbp7, a member of the insulin-like growth factor-binding proteins family and a tumor suppressor in itself, and show that re-introduction of Igfbp7 alone can hinder tumor development. Our results define a novel mechanism for Smarcb1-mediated tumorigenesis and highlight potential therapeutic targets.

journal_name

Oncogene

journal_title

Oncogene

authors

Darr J,Klochendler A,Isaac S,Eden A

doi

10.1038/onc.2013.261

subject

Has Abstract

pub_date

2014-06-05 00:00:00

pages

3024-32

issue

23

eissn

0950-9232

issn

1476-5594

pii

onc2013261

journal_volume

33

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.

    abstract::REF cells transformed by oncogenes E1A and cHa-ras reveal high and constitutive DNA-binding activity of AP-1 factor lacking in c-Fos protein. Consistently, the transcription of c-fos gene has been found to be downregulated. To elucidate the mechanisms of c-fos downregulation in E1A+cHa-ras transformants, we studied th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205118

    authors: Kukushkin AN,Abramova MV,Svetlikova SB,Darieva ZA,Pospelova TV,Pospelov VA

    更新日期:2002-01-24 00:00:00

  • Epstein-Barr virus U leader exon contains an internal ribosome entry site.

    abstract::Eukaryotic translation can be initiated either by a cap-dependent mechanism or by internal ribosome entry, a process by which ribosomes are directly recruited to structured regions of mRNA upstream of the initiation codon. Here we report the finding of an internal ribosome entry site (IRES) in the untranslated region ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206149

    authors: Isaksson A,Berggren M,Ricksten A

    更新日期:2003-01-30 00:00:00

  • Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.

    abstract::Fallopian tube carcinoma (FTC) is a rare, poorly studied and aggressive cancer, associated with poor survival. Since tumorigenesis is related to the acquisition of genetic changes, we used genome-wide array comparative genomic hybridization to analyse copy number aberrations occurring in FTC in order to obtain a bette...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206621

    authors: Snijders AM,Nowee ME,Fridlyand J,Piek JM,Dorsman JC,Jain AN,Pinkel D,van Diest PJ,Verheijen RH,Albertson DG

    更新日期:2003-07-03 00:00:00

  • Regulation of mitotic exit by the RNF8 ubiquitin ligase.

    abstract::RNF8 is a ubiquitin ligase with a FHA domain near its N terminus, and a RING-finger domain at its C terminus, through which it recruits several ubiquitin-conjugating enzymes. In metazoans, only the mitotic checkpoint regulator CHFR shares this domain architecture. Here we show that RNF8 is a nuclear protein that follo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210782

    authors: Plans V,Guerra-Rebollo M,Thomson TM

    更新日期:2008-02-28 00:00:00

  • miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.

    abstract::Non-small cell lung cancer (NSCLC) accounts for ∼80% of all lung cancers. Although some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.260

    authors: Acunzo M,Visone R,Romano G,Veronese A,Lovat F,Palmieri D,Bottoni A,Garofalo M,Gasparini P,Condorelli G,Chiariello M,Croce CM

    更新日期:2012-02-02 00:00:00

  • PCNA: structure, functions and interactions.

    abstract::Proliferating cell nuclear antigen (PCNA) plays an essential role in nucleic acid metabolism as a component of the replication and repair machinery. This toroidal-shaped protein encircles DNA and can slide bidirectionally along the duplex. One of the well-established functions for PCNA is its role as the processivity ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1200886

    authors: Kelman Z

    更新日期:1997-02-13 00:00:00

  • HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.

    abstract::It has recently been shown that the high-risk human papillomavirus (HPV) E6 proteins can target the PDZ-domain containing proteins, Dlg, MUPP-1, MAGI-1 and hScrib for proteasome-mediated degradation. However, the E6 proteins from HPV-16 and HPV-18 (the two most common high-risk virus types) differ in their ability to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204719

    authors: Thomas M,Glaunsinger B,Pim D,Javier R,Banks L

    更新日期:2001-09-06 00:00:00

  • p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis.

    abstract::p8 is a stress-induced DNA-binding protein, biochemically related to the architectural chromatin binding HMG protein family and whose function is presently unknown. We obtained fibroblast from mice lacking p8 and found that p8 is involved in cell growth regulation and in apoptosis. p8(-/-) mouse embryonic fibroblasts ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205222

    authors: Vasseur S,Hoffmeister A,Garcia-Montero A,Mallo GV,Feil R,Kühbandner S,Dagorn JC,Iovanna JL

    更新日期:2002-03-07 00:00:00

  • Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines.

    abstract::The p21WAF1/CIP1 protein was shown to be a critical downstream effector of p53 and a potent inhibitor of cyclin-dependent kinases. We investigated the effects of exogenous p21WAF1/CIP1 in two different human breast carcinoma (HBC) cell lines MCF-7 and T47D. p21WAF1/CIP1 transfected cells formed significantly reduced n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sheikh MS,Rochefort H,Garcia M

    更新日期:1995-11-02 00:00:00

  • The Rafts of the Medusa: cholesterol targeting in cancer therapy.

    abstract::In this issue of Oncogene, Mollinedo and co-workers present promising evidence that cholesterol-sensitive signaling pathways involving lipid rafts can be therapeutically targeted in multiple myeloma. Because the pathways considered in their study are used by other types of tumor cells, one implication of this report i...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2010.132

    authors: Freeman MR,Di Vizio D,Solomon KR

    更新日期:2010-07-01 00:00:00

  • TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation.

    abstract::The p14ARF tumor suppressor is a key regulator of cellular proliferation, frequently inactivated in human cancer. The mechanisms that regulate alternative reading frame (ARF) turnover have been obscure for long time, being ARF a relatively stable protein. Recently, it has been described that its degradation depends, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210313

    authors: Pollice A,Sepe M,Villella VR,Tolino F,Vivo M,Calabrò V,La Mantia G

    更新日期:2007-08-02 00:00:00

  • Molecular cloning of the epidermal growth factor-stimulated protein kinase p56 KKIAMRE.

    abstract::A 56 kDa protein kinase was molecularly cloned from human fetal brain. This protein kinase (p56 KKIAMRE) shares homology with p42 KKIALRE (Meyerson et al., 1992) and is related to the proline-directed protein kinase group of signal transducing enzymes. The p56 KKIAMRE and p42 KKIALRE protein kinases exhibit mutually e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Taglienti CA,Wysk M,Davis RJ

    更新日期:1996-12-19 00:00:00

  • Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.

    abstract::Epithelial-to-mesenchymal transition (EMT), marked by the dissolution of cell-cell junctions, loss of cell polarity and increased cell motility, is one of the essential steps for prostate cancer metastasis. However, the underlying mechanism has not been fully explored. We report in this study that Shp2 is upregulated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.184

    authors: Zhang K,Zhao H,Ji Z,Zhang C,Zhou P,Wang L,Chen Q,Wang J,Zhang P,Chen Z,Zhu HH,Gao WQ

    更新日期:2016-03-10 00:00:00

  • Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

    abstract::A hallmark of cancer is the deregulation of cell-cycle machinery, ultimately facilitating aberrant proliferation that fuels tumorigenesis and disease progression. Particularly, in breast cancers, cyclin D1 has a crucial role in the development of disease. Recently, a highly specific inhibitor of CDK4/6 activity (PD-03...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.154

    authors: Dean JL,Thangavel C,McClendon AK,Reed CA,Knudsen ES

    更新日期:2010-07-15 00:00:00

  • Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation.

    abstract::The growth and progression of prostate cancer are dependent on androgens and androgen receptor (AR), which act by modulating gene expression. Utilizing a gene microarray approach, we have identified the alpha1-subunit gene of soluble guanylyl cyclase (sGC) as a novel androgen-regulated gene. A heterodimeric cytoplasmi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209956

    authors: Cai C,Chen SY,Zheng Z,Omwancha J,Lin MF,Balk SP,Shemshedini L

    更新日期:2007-03-08 00:00:00

  • IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.

    abstract::Various factors and cellular components in the tumor microenvironment are key drivers associated with drug resistance in many cancers. Here, we analyzed the factors and molecular mechanisms involved in chemoresistance in patients with esophageal squamous cell carcinoma (ESCC). We found that interleukin 6 (IL6) derived...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.387

    authors: Qiao Y,Zhang C,Li A,Wang D,Luo Z,Ping Y,Zhou B,Liu S,Li H,Yue D,Zhang Z,Chen X,Shen Z,Lian J,Li Y,Wang S,Li F,Huang L,Wang L,Zhang B,Yu J,Qin Z,Zhang Y

    更新日期:2018-02-15 00:00:00

  • Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis.

    abstract::I briefly review the discovery and characterization of the first human retrovirus, human T-cell leukemia virus type 1, focusing on contributions from Japanese researchers. The unique regulatory mechanisms for the viral regulation with Tax and Rex, etiology of ATL and possible leukemogenic mechanism with Tax are also d...

    journal_title:Oncogene

    pub_type: 历史文章,杂志文章,评审

    doi:10.1038/sj.onc.1208981

    authors: Yoshida M

    更新日期:2005-09-05 00:00:00

  • Suppression in transformed avian fibroblasts of a gene (CO6) encoding a membrane protein related to mammalian potassium channel regulatory subunits.

    abstract::Gene expression patterns in normal and v-myc-transformed quail embryo fibroblasts were compared by mRNA differential display. Displaying approximately 2500 mRNA species by reverse transcription/PCR, reamplification of 73 differential cDNA fragments and rescreening by Northern analysis led to the isolation of a clone, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200930

    authors: Oberst C,Weiskirchen R,Hartl M,Bister K

    更新日期:1997-03-06 00:00:00

  • Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.

    abstract::Intrinsic and acquired resistance to anti-EGFR antibody therapy, frequently mediated by a mutant or amplified KRAS oncogene, is a significant challenge in the treatment of colorectal cancer (CRC). However, the mechanism of KRAS-mediated therapeutic resistance is not well understood. In this study, we demonstrate that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0289-x

    authors: Knickelbein K,Tong J,Chen D,Wang YJ,Misale S,Bardelli A,Yu J,Zhang L

    更新日期:2018-08-01 00:00:00

  • Genetics of melanoma predisposition.

    abstract::Predisposition to melanoma is genetically heterogeneous. Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others. With the advent of a catalogue of millions of potential DNA polymorphisms, attention is now also being focused on ident...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206445

    authors: Hayward NK

    更新日期:2003-05-19 00:00:00

  • K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death.

    abstract::Fas-associated death domain (FADD) is an adaptor protein recruiting complexes of caspase 8 to death ligand receptors to induce extrinsic apoptotic cell death in response to a TNF superfamily member. Although, formation of the complex of FADD and caspase 8 upon death stimuli has been studied in detail, posttranslationa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0323-z

    authors: Seo J,Lee EW,Shin J,Seong D,Nam YW,Jeong M,Lee SH,Lee C,Song J

    更新日期:2018-09-01 00:00:00

  • p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment.

    abstract::Solid tumors frequently contain hypoxic subregions due to insufficient blood supply. In these domains, cells can undergo p53-dependent apoptosis. Therefore, hypoxia has been implicated as a physiological stimulus for p53 accumulation and activation. In such an environment, p53 mutant cells exhibit a selective growth a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207657

    authors: Pan Y,Oprysko PR,Asham AM,Koch CJ,Simon MC

    更新日期:2004-06-24 00:00:00

  • A novel p53 germline alteration identified in a late onset breast cancer kindred.

    abstract::Germline mutations in the p53 tumor suppressor gene are associated with the Li-Fraumeni syndrome, characterized by childhood sarcoma, leukemia and early onset breast cancer and has occasionally been found also in familial breast-ovarian cancer. Most mutations found are of missense type and located in the central regio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sun XF,Johannsson O,Håkansson S,Sellberg G,Nordenskjöld B,Olsson H,Borg A

    更新日期:1996-07-18 00:00:00

  • Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death.

    abstract::Evasion of apoptosis in pediatric acute lymphoblastic leukemia (ALL) is linked to aberrant expression of inhibitor of apoptosis (IAP) proteins and dysregulated redox homeostasis, rendering leukemic cells vulnerable to redox-targeting therapies. Here we discover that inhibition of antioxidant defenses via glutathione (...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.338

    authors: Schoeneberger H,Belz K,Schenk B,Fulda S

    更新日期:2015-07-30 00:00:00

  • 5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells.

    abstract::Treating lung cancer cell lines using low-dose 5-aza-2'-deoxycytidine (DAC) caused an accumulation of procaspase-9 through mRNA upregulation, but the cells did not undergo apoptosis. However, when cells were treated with DAC and infected with a low dose of a recombinant wild-type p53 adenovirus vector (Ad-p53), a syne...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207381

    authors: Gomyo Y,Sasaki J,Branch C,Roth JA,Mukhopadhyay T

    更新日期:2004-09-02 00:00:00

  • Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.

    abstract::Anaplastic lymphoma kinase (ALK) was originally identified from a rare subtype of non-Hodgkin's lymphomas carrying t(2;5)(p23;q35) translocation, where ALK was constitutively activated as a result of a fusion with nucleophosmin (NPM). Aberrant ALK fusion proteins were also generated in inflammatory fibrosarcoma and a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.616

    authors: Okubo J,Takita J,Chen Y,Oki K,Nishimura R,Kato M,Sanada M,Hiwatari M,Hayashi Y,Igarashi T,Ogawa S

    更新日期:2012-11-01 00:00:00

  • Induction of telomerase activity by UV-irradiation in Chinese hamster cells.

    abstract::Telomerase is a ribonucleoprotein whose activity has been detected in germline cells and in neoplastic and immortal cells. Telomerase compensates the telomere loss arising by the end replication problem by synthesizing telomeric repeats at the 3' end of the eukaryotic chromosomes. Telomerase is reactivated during canc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201327

    authors: Hande MP,Balajee AS,Natarajan AT

    更新日期:1997-10-02 00:00:00

  • CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.

    abstract::CD97, a member of the adhesion family of G-protein-coupled receptors (GPCRs), complexes with and potentiates lysophosphatidic acid (LPA) receptor signaling to the downstream effector RHOA. We show here that CD97 was expressed in a majority of thyroid cancers but not normal thyroid epithelium and that the level of CD97...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.301

    authors: Ward Y,Lake R,Martin PL,Killian K,Salerno P,Wang T,Meltzer P,Merino M,Cheng SY,Santoro M,Garcia-Rostan G,Kelly K

    更新日期:2013-05-30 00:00:00

  • A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer.

    abstract::Targeted cancer therapies, although often effective, have limited utility owing to preexisting primary or acquired secondary resistance. Consequently, agents are sometimes used in combination to simultaneously affect multiple targets. MicroRNA mimics are excellent therapeutic candidates because of their ability to rep...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.282

    authors: Kasinski AL,Kelnar K,Stahlhut C,Orellana E,Zhao J,Shimer E,Dysart S,Chen X,Bader AG,Slack FJ

    更新日期:2015-07-01 00:00:00

  • A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4.

    abstract::In a previous work we provided preliminary evidence of the existence of a putative tumor suppressor gene region on the distal part of chromosome 4 in gamma-radiation-induced T-cell lymphomas of (C57BL/6J x RF/J) F1 hybrid mice. This region, named as TLSR2 (Thymic Lymphoma Suppressor Region 2), was located centered at ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202009

    authors: Santos J,Herranz M,Pérez de Castro I,Pellicer A,Fernández-Piqueras J

    更新日期:1998-08-20 00:00:00